共 9 条
[1]
Niemengeers CJ., Antiemetic specificity of dopamine antagonists, Psychopharmacology, 78, pp. 210-213, (1982)
[2]
Duarte DF, Linhares S, Gesser N, Pederneiras SG., Effect of intramuscular clebopride on postoperative nausea and vomiting, Clin Ther, 7, pp. 365-371, (1985)
[3]
Kilpatrick GJ, Tayar NE, Van de Waterbeemd H, Jenner P, Testa B, Marsden CD., The thermodynamics of agonist and antagonist binding to dopamine D2 receptors, Mol Pharmacol, 30, pp. 226-234, (1986)
[4]
Fleminger S, Van de Waterbeemd H, Rupniak NM, Et al., Potent lipophilic substituted benzamide drugs are not selective D1 dopamine receptor antagonists in the rat, J Pharm Pharmacol, 35, pp. 363-368, (1983)
[5]
Chivers JK, Gommeren W, Leysen JE, Jenner P, Marsden CD., Comparison of the in‐vitro receptor selectivity of substituted benzamide drugs for brain neurotransmitter receptors, J Pharm Pharmacol, 40, pp. 415-421, (1988)
[6]
Lopez Rois F, Conce Pico M, Calvo Fernandez J, Novo I, Castro Gago M., Sindrome extrapiramidal medicamentoso. A proposito de 22 observaciones, An Esp Pediatr, 26, pp. 91-93, (1987)
[7]
Martin M, Diaz-Rubio E., Estudio comparativo de la tolerancia y eficacia de las altas doses de metoclopramide y clebopride en los vomitos inducidos por cisplatino, Med Clin (Barc), 93, pp. 50-53, (1989)
[8]
Bavestrello L, Caimi L, Barbera A., A double‐blind comparison of clebopride and placebo in dyspepsia secondary to delayed gastric emptying, Clin Ther, 7, pp. 468-473, (1985)
[9]
Perez-Lopez FR, Legido A, Sisskin M, Abos MD., Stimulatory effects of clebopride on human prolactin secretion, Fertil Steril, 34, pp. 452-455, (1980)